Clinical Trial Update: Autologous BM-MSC Transplantation in Combination With Platelet Lysate (PL) for Nonunion Treatment [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on autologous bone marrow-derived mesenchymal stem cell transplantation combined with platelet lysate for nonunion of bone fractures. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Fracture
• Nonunion of Fracture

Drugs mentioned

• Autologous Bone Marrow-Derived Mesenchymal Stem Cell Transplantation (bone marrow-derived mesenchymal stem cells)
• Platelet Lysate (platelet lysate)

Snippet

Sponsor: Royan Institute | Conditions: Bone Fracture | Phase 2, Phase 3 | Status: UNKNOWN